| scholarly article | Q13442814 |
| P356 | DOI | 10.1345/APH.1R530 |
| P698 | PubMed publication ID | 23613095 |
| P2093 | author name string | Lauren M Hynicka | |
| Kathleen J Pincus | |||
| P2860 | cites work | Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q24633053 |
| Nephrotic syndrome in adults | Q24650808 | ||
| The Management of Idiopathic Nephrotic Syndrome in Children | Q28195778 | ||
| Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) | Q28284893 | ||
| Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q33399576 | ||
| Nephrotic syndrome and coagulation and fibrinolytic abnormalities | Q33477949 | ||
| Clinical burden of venous thromboembolism | Q33687634 | ||
| Statins in the prevention of venous thromboembolism: a meta-analysis of observational studies | Q33922716 | ||
| Warfarin dosing in patients with impaired kidney function | Q34238435 | ||
| Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum | Q34643324 | ||
| The epidemiology of venous thromboembolism. | Q35157791 | ||
| The epidemiology of venous thromboembolism in the community: implications for prevention and management | Q36395263 | ||
| Renal vein thrombosis in nephrotic syndrome—a prospective study and review | Q36716805 | ||
| Statin use and the prevention of venous thromboembolism: a meta-analysis | Q37780572 | ||
| Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome | Q39835409 | ||
| Venous thromboembolism in patients hospitalized with nephrotic syndrome | Q43690932 | ||
| Thromboembolic complications in membranous nephropathy patients with nephrotic syndrome-a prospective study | Q44791452 | ||
| Activation of hageman factor in the nephrotic syndrome | Q47882844 | ||
| High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. | Q51111868 | ||
| Statin use in patients with nephrotic syndrome is associated with a lower risk of venous thromboembolism. | Q51158130 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thromboembolism | Q891391 |
| P304 | page(s) | 725-734 | |
| P577 | publication date | 2013-04-23 | |
| P1433 | published in | Annals of Pharmacotherapy | Q4767858 |
| P1476 | title | Prophylaxis of thromboembolic events in patients with nephrotic syndrome | |
| P478 | volume | 47 |
| Q46030902 | Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome. |
| Q28077600 | Case Report: Acute Cerebellar Thrombosis in an Adult Patient with IgM Nephropathy |
| Q55509896 | Direct-Acting Oral Anticoagulants as Prophylaxis Against Thromboembolism in the Nephrotic Syndrome. |
| Q49647319 | Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants. |
| Q50441427 | Heparin calcium treated Henoch-Schönlein purpura nephritis in children through inhibiting hyperfibrinolysis |
| Q37521142 | Minimal Change Nephrotic Syndrome Sequentially Complicated by Acute Kidney Injury and Painful Skin Ulcers due to Calciphylaxis |
| Q59384153 | Platelet abnormalities in nephrotic syndrome |
| Q64087597 | Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications |
| Q41232321 | Retroperitoneal Bleeding: An Experience During Prophylactic Anticoagulation in a Patient With Nephrotic Syndrome |
| Q38468532 | Risks and benefits of low molecular-weight heparin and target-specific oral anticoagulant use for thromboprophylaxis in medically ill patients |
| Q38594110 | SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014. |
| Q40679079 | Significance of venous thromboembolism in women with cervical cancer. |
| Q38132611 | The nephrotic syndrome: pathogenesis and treatment of edema formation and secondary complications |
| Q91589497 | The role of prophylactic use of low molecular weight heparin or aspirin in thromboembolic events in primary membranous nephropathy |
| Q37395624 | Therapeutic Dilemmas Regarding Anticoagulation: An Experience in a Patient with Nephrotic Syndrome, Pulmonary Embolism, and Traumatic Brain Injury |
| Q53084898 | Use of rivaroxaban in a patient with history of nephrotic syndrome and hypercoagulability. |
| Q45881550 | Vitamin K antagonists in children with central venous catheter on chronic haemodialysis: a pilot study. |
| Q33410001 | Women, kidney disease, and pregnancy |
Search more.